CVE-2022-43126: n/a in n/a
Online Diagnostic Lab Management System v1.0 was discovered to contain a SQL injection vulnerability via the id parameter at /admin/tests/manage_test.php.
AI Analysis
Technical Summary
CVE-2022-43126 is a high-severity SQL injection vulnerability identified in the Online Diagnostic Lab Management System version 1.0. The vulnerability exists in the 'id' parameter of the '/admin/tests/manage_test.php' endpoint. SQL injection (CWE-89) vulnerabilities allow attackers to manipulate backend SQL queries by injecting malicious input, potentially leading to unauthorized data access, data modification, or even full system compromise. According to the CVSS 3.1 vector (7.2), the attack vector is network-based (AV:N), requiring low attack complexity (AC:L), but requires high privileges (PR:H) and no user interaction (UI:N). The scope is unchanged (S:U), and the impact on confidentiality, integrity, and availability is high (C:H/I:H/A:H). This means an attacker with administrative privileges on the system can exploit this vulnerability remotely without user interaction to fully compromise the database and potentially the underlying system. No patches or vendor information are currently available, and no known exploits in the wild have been reported. The vulnerability was published on November 1, 2022, and is tracked by MITRE and CISA. The lack of vendor or product details limits precise identification, but the affected system is a diagnostic lab management application, which likely handles sensitive medical and patient data.
Potential Impact
For European organizations, especially healthcare providers and diagnostic laboratories using this or similar lab management systems, the impact could be severe. Exploitation could lead to unauthorized access to sensitive patient data, including medical test results and personal information, violating GDPR and other data protection regulations. This could result in significant legal penalties, reputational damage, and loss of patient trust. Additionally, attackers could alter or delete diagnostic data, impacting patient care and clinical decision-making. The high integrity and availability impact means that system disruption could delay critical medical testing services. Given the critical nature of healthcare infrastructure in Europe, such vulnerabilities pose a risk not only to individual organizations but also to public health and safety.
Mitigation Recommendations
Organizations should immediately audit their diagnostic lab management systems for the presence of this vulnerability, focusing on the 'id' parameter in the '/admin/tests/manage_test.php' endpoint. Since no official patch is currently available, mitigation should include implementing strict input validation and parameterized queries (prepared statements) to prevent SQL injection. Access controls should be reviewed and tightened to ensure that only necessary users have administrative privileges, reducing the risk posed by the requirement for high privileges to exploit. Network-level protections such as web application firewalls (WAFs) can be configured to detect and block SQL injection attempts targeting this endpoint. Regular security assessments and code reviews should be conducted to identify similar vulnerabilities. Organizations should also monitor logs for suspicious activity related to this endpoint and prepare incident response plans in case of exploitation. Finally, engaging with vendors or developers to obtain patches or updates is critical once available.
Affected Countries
Germany, France, United Kingdom, Italy, Spain, Netherlands, Belgium, Sweden
CVE-2022-43126: n/a in n/a
Description
Online Diagnostic Lab Management System v1.0 was discovered to contain a SQL injection vulnerability via the id parameter at /admin/tests/manage_test.php.
AI-Powered Analysis
Technical Analysis
CVE-2022-43126 is a high-severity SQL injection vulnerability identified in the Online Diagnostic Lab Management System version 1.0. The vulnerability exists in the 'id' parameter of the '/admin/tests/manage_test.php' endpoint. SQL injection (CWE-89) vulnerabilities allow attackers to manipulate backend SQL queries by injecting malicious input, potentially leading to unauthorized data access, data modification, or even full system compromise. According to the CVSS 3.1 vector (7.2), the attack vector is network-based (AV:N), requiring low attack complexity (AC:L), but requires high privileges (PR:H) and no user interaction (UI:N). The scope is unchanged (S:U), and the impact on confidentiality, integrity, and availability is high (C:H/I:H/A:H). This means an attacker with administrative privileges on the system can exploit this vulnerability remotely without user interaction to fully compromise the database and potentially the underlying system. No patches or vendor information are currently available, and no known exploits in the wild have been reported. The vulnerability was published on November 1, 2022, and is tracked by MITRE and CISA. The lack of vendor or product details limits precise identification, but the affected system is a diagnostic lab management application, which likely handles sensitive medical and patient data.
Potential Impact
For European organizations, especially healthcare providers and diagnostic laboratories using this or similar lab management systems, the impact could be severe. Exploitation could lead to unauthorized access to sensitive patient data, including medical test results and personal information, violating GDPR and other data protection regulations. This could result in significant legal penalties, reputational damage, and loss of patient trust. Additionally, attackers could alter or delete diagnostic data, impacting patient care and clinical decision-making. The high integrity and availability impact means that system disruption could delay critical medical testing services. Given the critical nature of healthcare infrastructure in Europe, such vulnerabilities pose a risk not only to individual organizations but also to public health and safety.
Mitigation Recommendations
Organizations should immediately audit their diagnostic lab management systems for the presence of this vulnerability, focusing on the 'id' parameter in the '/admin/tests/manage_test.php' endpoint. Since no official patch is currently available, mitigation should include implementing strict input validation and parameterized queries (prepared statements) to prevent SQL injection. Access controls should be reviewed and tightened to ensure that only necessary users have administrative privileges, reducing the risk posed by the requirement for high privileges to exploit. Network-level protections such as web application firewalls (WAFs) can be configured to detect and block SQL injection attempts targeting this endpoint. Regular security assessments and code reviews should be conducted to identify similar vulnerabilities. Organizations should also monitor logs for suspicious activity related to this endpoint and prepare incident response plans in case of exploitation. Finally, engaging with vendors or developers to obtain patches or updates is critical once available.
Affected Countries
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- mitre
- Date Reserved
- 2022-10-17T00:00:00.000Z
- Cisa Enriched
- true
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 682d981fc4522896dcbdc69e
Added to database: 5/21/2025, 9:08:47 AM
Last enriched: 7/3/2025, 12:59:11 PM
Last updated: 8/17/2025, 2:28:00 AM
Views: 14
Related Threats
CVE-2025-3495: CWE-338 Use of Cryptographically Weak Pseudo-Random Number Generator (PRNG) in Delta Electronics COMMGR
CriticalCVE-2025-53948: CWE-415 Double Free in Santesoft Sante PACS Server
HighCVE-2025-52584: CWE-122 Heap-based Buffer Overflow in Ashlar-Vellum Cobalt
HighCVE-2025-46269: CWE-122 Heap-based Buffer Overflow in Ashlar-Vellum Cobalt
HighCVE-2025-54862: CWE-79 Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') in Santesoft Sante PACS Server
MediumActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.